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Abstract
Cigarette smoke (CS) causes sustained lung inflammation, which is an important event in the pathogenesis of chronic
obstructive pulmonary disease (COPD). We have previously reported that IKKa (I kappaB kinase alpha) plays a key role in CS-
induced pro-inflammatory gene transcription by chromatin modifications; however, the underlying role of downstream
signaling kinase is not known. Mitogen- and stress-activated kinase 1 (MSK1) serves as a specific downstream NF-kB RelA/
p65 kinase, mediating transcriptional activation of NF-kB-dependent pro-inflammatory genes. The role of MSK1 in nuclear
signaling and chromatin modifications is not known, particularly in response to environmental stimuli. We hypothesized
that MSK1 regulates chromatin modifications of pro-inflammatory gene promoters in response to CS. Here, we report that
CS extract activates MSK1 in human lung epithelial (H292 and BEAS-2B) cell lines, human primary small airway epithelial cells
(SAEC), and in mouse lung, resulting in phosphorylation of nuclear MSK1 (Thr581), phospho-acetylation of RelA/p65 at
Ser276 and Lys310 respectively. This event was associated with phospho-acetylation of histone H3 (Ser10/Lys9) and
acetylation of histone H4 (Lys12). MSK1 N- and C-terminal kinase-dead mutants, MSK1 siRNA-mediated knock-down in
transiently transfected H292 cells, and MSK1 stable knock-down mouse embryonic fibroblasts significantly reduced CS
extract-induced MSK1, NF-kB RelA/p65 activation, and posttranslational modifications of histones. CS extract/CS promotes
the direct interaction of MSK1 with RelA/p65 and p300 in epithelial cells and in mouse lung. Furthermore, CS-mediated
recruitment of MSK1 and its substrates to the promoters of NF-kB-dependent pro-inflammatory genes leads to
transcriptional activation, as determined by chromatin immunoprecipitation. Thus, MSK1 is an important downstream
kinase involved in CS-induced NF-kB activation and chromatin modifications, which have implications in pathogenesis of
COPD.
Citation: Sundar IK, Chung S, Hwang J-w, Lapek JD Jr, Bulger M, et al. (2012) Mitogen- and Stress-Activated Kinase 1 (MSK1) Regulates Cigarette Smoke-Induced
Histone Modifications on NF-kB-dependent Genes. PLoS ONE 7(2): e31378. doi:10.1371/journal.pone.0031378
Editor: Neeraj Vij, Johns Hopkins School of Medicine, United States of America
Received May 20, 2011; Accepted January 8, 2012; Published February 1, 2012
Copyright:  2012 Sundar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the NIH – National Heart, Lung, and Blood Institute Grant R01-HL085613, National Institute of Environmental Health
Sciences Center Grant NIEHS P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Irfan_Rahman@urmc.rochester.edu
Introduction
Cigarette smoke (CS) contains more than 10
14–16 free radicals/
oxidants per puff and is composed of ,4700 chemical compounds,
including a major aldehyde, acrolein. CS mediates pro-inflamma-
tory effects by carbonyl and oxidative stress in the lung via the
generation of reactive oxygen species (ROS) and aldehydes, as well
as through endogenous generation of ROS from inflammatory/
structural cells [1,2]. Pulmonary inflammatory response due to the
infiltration of macrophages and neutrophils in the interstitium
plays a central role in the pathogenesis of chronic obstructive
pulmonary disease (COPD) [3,4]. Furthermore, chronic CS
exposure to mice leads to increased lung inflammatory response
and airspace enlargement, which are characteristics of COPD/
pulmonary emphysema [2,5]. Inflammatory cells release numer-
ous mediators that can cause airway constriction and remodeling.
These cells also produce proteases (elastase, cathepsins, gran-
zymes, and MMPs) that can cause destruction of lung parenchyma
leading to airspace enlargement [2,4,5]. Changes in the levels of
pro-inflammatory mediators are associated with activation of
specific transcription factors, such as nuclear factor-kappaB (NF-
kB), in the lung [1,3,6]. Site-specific posttranslational modifica-
tions, such as phosphorylation and acetylation of RelA/p65 (a
subunit of NF-kB), play an essential role in NF-kB activation and
CS-mediated lung inflammation [7,8].
Mitogen- and stress-activated protein kinase 1 (MSK1) plays an
important role in transcriptional activation of NF-kB-dependent
pro-inflammatory genes, but the mechanism by which it functions,
including the potential roles in chromatin modifications in
response to environmental stimuli, is not known. MSK1 is a
nuclear kinase that in a stimulus-dependent fashion associates with
RelA/p65 and phosphorylates RelA/p65 at Ser276. Hence,
MSK1 serves as a specific NF-kB RelA/p65 kinase, which may
have an important signaling intermediate for chromatin modifi-
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aldehydes cause chromatin modifications on pro-inflammatory
gene promoters, leading to sustained lung inflammation in
smokers and patients with COPD [1,2,10], but the underlying
mechanism for chromatin modifications, leading to histone
acetylation on promoters of pro-inflammatory genes remains
poorly understood. We hypothesized that MSK1 mediates
chromatin modifications and forms multi-nuclear complexes with
RelA/p65 and p300 in response to CS on promoters of pro-
inflammatory genes.
MSK1 mediates the growth-factor, cellular and mitogenic
stress-induced activation of transcription factors and chromatin
proteins, such as cAMP-response-element-binding (CREB),
activating transcription factor 1 (ATF1), NF-kB, and the
chromatin protein histone H3, and high-mobility group protein
(HMG) 14 [11,12,13]. In humans, phosphorylation at Thr581
located within the C-terminal kinase domain is essential for
activation of MSK1 [13]. Hence, it is possible that environmen-
tal stimuli, such as cigarette smoke may activate MSK1 via
phosphorylation of Thr581. Phosphorylation of NF-kBa t
Ser276 promotes the recruitment of the transcriptional coacti-
v a t o rp 3 0 0 / C B P ,w h i c hi nt u r na c e t y l a t e sb o t hR e l A / p 6 5a n d
histones at NF-kB bound promoters [7,14]. However, the role of
MSK1 in transcriptional activation of NF-kB RelA/p65 and
histone modifications by CS is not known. Here, we report that
CS induces histone modifications via MSK1 and phospho-
acetylation of RelA/p65, followed by recruitment of MSK1 and
its substrates to the promoters of pro-inflammatory genes,
thereby increasing transcription of genes encoding pro-inflam-
matory mediators. Our data reveals the mechanism by which
MSK1 is involved in CS-mediated NF-kB activation and
chromatin modifications in human bronchial epithelial cells
(H292 and BEAS-2B), human primary small airway epithelial
cells (SAEC), and in lungs of mice exposed to CS. We report for
the first time that CS-mediated activation of MSK1 forms a
complex with NF-kB RelA/p65 and p300, which plays a key role
in histone modifications of NF-kB-dependent pro-inflammatory
gene promoters.
Materials and Methods
Ethics statement
All experimental protocols were performed in accordance with
the standards established by the United States Animal Welfare
Act, as set forth by the National Institutes of Health guidelines.
The research protocol for these studies was approved by the
University of Rochester Committee on Animal Research.
Materials
Unless otherwise stated, all biochemical reagents used in this
study were purchased from Sigma Chemicals (St. Louis, MO,
USA). Penicillin-streptomycin, L-glutamine and RPMI-1640
were obtained from Gibco BRL (Grand Island, NY). Fetal
bovine serum (FBS) was obtained from HyClone Laboratories
(Logan, UT). Dulbecco’s modified Eagle’s medium-Ham’s F12
50:50 mixture (DMEM-F12) was purchased from Mediatech
(Manassas, VA). Amphotericin B was purchased from Lonza
(Walkersville, MD). MSK1, p-S276 (RelA/p65), RelA/p65, and
Lamin B antibodies were obtained from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Anti-Flag M2, and a ˆ-actin antibodies were
obtained from Sigma. p-MSK1 (Thr581), Ac-K310 RelA/p65, p-
Ac-(Ser10/Lys9) histone H3, Ac-(Lys12) histone H4, histone H3
and histone H4 antibodies were obtained from Cell Signaling
(Danvers, MA).
Cell culture
Human bronchial epithelial cells (H292) were obtained from
the American Type Culture Collection (ATCC) (Manassas, VA).
H292 cells were grown in RPMI-1640 supplemented with 10%
FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin. Human bronchial epithelial cells (BEAS-2B) [15]
obtained from ATCC were grown in DMEM-F12 50:50
mixture (DMEM-F12; Mediatech, Manassas, VA USA) supple-
mented with 5% FBS, 15 mM HEPES, 100 mg/ml penicillin,
and 100 U/ml streptomycin. Human small airway epithelial
cells (SAECs) derived from a single healthy donor were
purchased from Lonza (formerly Cambrex, Walkersville, MD,
USA) along with growth medium [Small Airway Epithelial Cell
Growth Medium (SAGM)] bullet kit
TM supplemented with
other factors as provided by the supplier. The cells were
cultured at 37uC in a humidified atmosphere containing 7.5%
CO2. Mouse embryonic fibroblast (MEF) 10T1/2 (wild-type)
and stable MSK1 knockdown 10T1/2 cells were grown in a ´-
MEM medium supplemented with 10% FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin and 250 ng/ml amphoter-
icin B. Puromycin was used as selection agent (8 mg/ml) for the
growth and maintenance of stable MSK1 knockdown cells [16].
MEF were cultured at 37uCi nah u m i d i f i e da t m o s p h e r e
containing 5% CO2.
Recombinant cDNA constructs, siRNA, and stable MSK1
knock-out mouse embryonic fibroblasts
pCMV-FLAG-MSK1 wild-type, pCMV-FLAG-MSK1 D195A
(N-terminal kinase-dead mutant denoted as ND mutant) and
pCMV-FLAG-MSK1 D565A (C-terminal kinase-dead mutant
denoted as CD mutant) were kind gifts from Dr. Simon J Arthur
(MRC Protein Phosphorylation Unit, School of Life Sciences,
University of Dundee, Scotland, UK) [17]. Flag-p65 wild-type and
Flag-p65 S276A (mutant) were kind gifts from Dr. James M.
Samet (Center for Environmental Medicine Asthma and Lung
Biology, University of North Carolina, Chapel Hill, NC) [18].
Knock-down of MSK1 expression in H292 cells was achieved by
transfection of small interfering RNAs (siRNA). The siRNAs of
human MSK1 (On-TARGET-Plus SMART Pool human
RPS6KA5; Cat# L-004665-00) and silencer-negative control
siRNA (Non-Targeting siRNA; Cat# D-001210-01-00) were
purchased from Dharmacon (Thermo Scientific, Lafayette, CO).
Transfection of siRNA was performed using the DharmaFECT 2
transfection reagent according to the manufacturer’s instructions
(Thermo Scientific, Waltham, MA). Mouse fibroblast 10T1/2 cells
(wild-type) contained empty GIPZ lentiviral vector and MSK1
stable knock-down mouse fibroblast contained GIPZ lentiviral
shRNAmir clones for mouse MSK1. These cells were kindly
provided by Dr. James R. Davie (Manitoba Institute of Cell
Biology, University of Manitoba, Manitoba, Canada) [16].
Transfection
Recombinant plasmids used in the study were transiently
transfected into cells grown in 6-well culture plates (7.0610
5 cells)
or 100 mm dishes (4610
6 cells) in a total volume of 2 ml or 7 ml
RPMI-1640 containing 10% FBS without antibiotics overnight,
respectively. The cells were transiently transfected with recombi-
nant wild type and mutant vectors (4–8 mg) using Lipofectamine
2000 (Invitrogen, CA) according to the manufacturer’s instruc-
tions. Transfection efficiency in case of plasmid transfections was
.70%. H292 cells were treated with CSE (1% or 2%) for 1 hr
24 hrs after transfection and the whole cell lysate was used for
Western blot analysis.
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Research grade cigarettes 3R4F were obtained from the
Kentucky Tobacco Research and Development Center at the
University of Kentucky (Lexington, KY). Ten percent CSE was
prepared by bubbling smoke from one 3R4F research-grade
cigarette into 10 ml of culture medium at a rate of one cigarette/
min, as described previously [10,19], using a modification of the
method as described [20]. The pH of CSE was adjusted to 7.4 and
then sterile-filtered through a 0.45 mm filter (25-mm Acrodisc; Pall
Corporation, Ann Arbor, MI, USA). CSE preparation was
standardized by measuring the absorbance at 320 nm
(OD=1.0060.05). The spectral variations observed between
different CSE preparations at 320 nm were minimal. CSE
(10%), contains up to 394 mM acrolein [21] equivalent to
39.4 mM in 1% CSE. For each experiment, freshly prepared
CSE was diluted with culture media without FBS within 10 min of
preparation before use. Control medium was prepared by
bubbling air through 10 ml of culture medium without FBS,
adjusting pH to 7.4, and sterile filtering as described above.
Acrolein and acetaldehyde are the main aldehyde components
present in CS, and one cigarette yields ,500 mg of acrolein and
,1000 mg of acetaldehyde depending on cigarette type and
determination methods [21,22,23,24]. Moreover, we used CSE
(0.1%–2%) to treat cells, which is equivalent to ,10–40 mM
aldehydes present in CS [22].
Mouse cigarette smoke exposure
Wild-type (WT) mice of genetic background C57BL/6J
(Jackson Laboratory, Bar Harbor, ME, USA) were bred and
maintained under pathogen-free conditions with a 12 h light/dark
cycle in the vivarium facility of the University of Rochester. Adult
C57BL/6J mice were exposed to CS using research grade
cigarettes (3R4F) according to the Federal Trade Commission
protocol (1 puff/min of 2 s duration and 35 ml volume) using a
Baumgartner-Jaeger CSM2072i automatic CS generating ma-
chine (CH Technologies, Westwood, NJ). Mainstream CS was
diluted with filtered air and directed into the exposure chamber.
The smoke exposure [total particulate matter (TPM) in per cubic
meter of air] was monitored in real-time with a MicroDust Pro-
aerosol monitor (Casella CEL, Bedford, UK) and verified daily by
gravimetric sampling. The smoke concentration was set at a value
of ,300 mg/m
3 TPM by adjusting the flow rate of the diluted
medical air, and the level of carbon monoxide in the chamber was
350 ppm [1,2,10]. One cigarette yields ,500 mg of acrolein and
,1000 mg of acetaldehyde depending on cigarette type and
determination methods [21,22,23,24]. Hence, CS at a dose of
,300 mg/m
3 TPM (corresponding to human consumption of 1–
1.5 packs per day) [25] was used in our study. Mice (n=4 per
group) received two 1 h exposures (1 h apart) daily for three
consecutive days, and were sacrificed at 24 h post-final exposure.
Control mice were exposed to filtered air in an identical chamber
according to the same protocol as described for CS exposure. Mice
were anesthetized by an intraperitoneal injection of pentobarbital
sodium (100 mg/kg; Abbott Laboratories, Abbott Park, IL), and
then sacrificed by exsanguination 24 h after last exposure. The
lungs were removed en bloc and frozen for immunoblotting and
immunoprecipitation analyses.
Cell treatments
Human epithelial cells H292, BEAS-2B and SAEC cells (7610
5
and 4610
6) were grown in 6-well or 100 mm dishes to ,80–90%
confluency in respective cell culture medium with 0.5% FBS. The
cells were treated with CSE (0.1%, 0.5%, 1% and 2%) for 1 h at
37uC with 7.5% CO2. At the end of treatment, the cells were
washed with cold sterile Ca
2+/Mg
2+-free PBS and lysed using the
RIPA buffer supplemented with a protease inhibitor cocktail
(leupeptin, aprotinin, pepstatin, and PMSF) for whole cell extract
preparation. For CSE treatment, mouse embryonic fibroblast
(10T1/2 wild-type and MSK1 stable knockdown) cells were grown
,70–80% confluent. 10T1/2 cells were serum starved for 24 h in
a-MEM medium supplemented with 0.5% FBS and treated with
CSE (1%) for 1 hr at 37uC with 5% CO2.
Nuclear protein isolation and acid extraction of histone
proteins
For nuclear extracts, cells were lysed in buffer A (10 mM
HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA,
1 mM DTT, 0.5 mM PMSF). After 15 min, Nonidet P-40 was
added to a final concentration of 0.6% and vortexed for 15 sec.
Samples were centrifuged for collection of the supernantants
containing cytosolic proteins. The nuclear pellets were resus-
pended in buffer B (20 mM HEPES [pH 7.9], 0.4 M NaCl, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF). After 30 min
at 4uC lysates were centrifuged and supernatants containing the
nuclear proteins were stored at 280uC. The final pellet obtained
after nuclear extraction was used for preparation of histones by
acid-extraction. To the nuclear pellet, 150 ml of acid extraction
buffer containing 0.2 N HCl and 0.36 N H2SO4 was added. The
mixture was rotated on a rocker at 4uC for 6–18 hrs. If necessary,
the pellet was sonicated for 2 sec on ice and centrifuged at
14,000 g for 10 min at 4uC. Then the supernatant containing acid
extracted histones was transferred to a fresh tube and mixed with
1.1 ml of ice-cold acetone to precipitate histones. The tubes were
incubated in 220uC overnight, then centrifuged at 14,000 g for
10 min at 4uC. The pellet was washed again with ice-cold acetone
and centrifuged to remove the acid. The pellet was then air dried
and dissolved in sterile distilled water for protein quantification
using bicinchoninic acid (BCA) kit (Pierce, Rockford, IL, USA)
followed by immunoblot analysis.
Protein extraction from lung tissue
Mice were injected with sodium pentobarbital (100 mg/kg body
weight, i.p.; Abbott Laboratories, Chevy Chase, MD, USA) and
sacrificed by exsanguination. The lungs were removed en bloc, and
the left lungs were lavaged 3 times with 0.5 ml of 0.9% NaCl,
while the right lung lobe was frozen for immunoblot analysis. One
hundred milligrams of right lung lobe was mechanically
homogenized in 0.5 ml of ice-cold RIPA buffer supplemented
with a protease inhibitor cocktail (leupeptin, aprotinin, pepstatin,
and PMSF), and then placed on ice for 45 min to allow for total
cell lysis to occur. The homogenate was centrifuged at 13,000 g in
a bench-top centrifuge for 25 min at 4uC for removal of cellular
debris. The supernatant was then transferred to a fresh 1.7-ml
eppendorf tube and used as whole lysate.
Immunoblot analysis
Protein levels were measured using the BCA kit. Twenty
micrograms of whole cell extracts or nuclear extracts of epithelial
cells (BEAS-2B, H292 or SAEC) or 20 mg of protein from whole
lung homogenate were prepared as described above, subjected to
electrophoresis on 6.5% (for whole cell extracts or nuclear extracts)
or 14% (for acid-extracted histone proteins) SDS-PAGE gels and
transferred onto nitrocellulose membranes (Amersham, Arlington
Heights, IL, USA). The nitrocellulose membrane was blocked with
5% BSA and subsequently incubated overnight at 4uC with
specific primary antibodies (1:1000 dilution). After 3 washing steps
(10 min each), the levels of protein were detected by probing with
MSK1 Regulates Chromatin Modifications
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dilution) linked to horseradish peroxidase (Dako, Santa Barbara,
CA, USA) for 1 h, and bound complexes detected using the
enhanced chemiluminescence method (ECL; Perkin-Elmer, Wal-
tham, MA).
Immunoprecipitation
Transfected H292 cells were lysed in 100 ml lysis buffer and
250–500 mg cell lysate was immunoprecipitated overnight with
40 ml EZview Red anti-flag M2 affinity gel (Sigma). Beads were
washed with Tris-buffered saline and immuno-complexes separat-
ed by SDS–PAGE. For immunoprecipitation of RelA/p65,
MSK1, and p300, 500–1000 mg cell lysates (nuclear or whole cell
extracts) were incubated with 4 mg of specific antibodies overnight
at 4uC, then immunoprecipitated with protein A/G Agarose beads
(Santa Cruz Biotech) for 1 h at 4uC. Beads were washed with lysis
buffer, boiled for 5 min in 26 sample buffer and immuno-
complexes separated on SDS–PAGE. Proteins were transferred
overnight onto nitrocellulose membranes (Amersham) and probed
with respective primary antibodies overnight. After 3 washing
steps (10 min each), primary antibodies were detected using the
specific secondary anti-rabbit or -mouse antibodies for 1 h at room
temperature, and the bound complexes detected using the
enhanced chemiluminescence method (PerkinElmer).
Immunofluorescence
H292, SAEC, and mouse fibroblast 10T1/2 (wild-type) and
MSK1 stable knock-down mouse fibroblast cells were grown on 8-
well chamber slides (1610
4 cells/well), treated with CSE (1%) for
Table 1. Human pro-inflammatory gene promoters primer
sequences used in chromatin immunoprecipitation assay.
Gene Primer Sequence
PCR product
(bp)
IL-6 Sense 59-TTGCGATGCTAAAGGACG-39
Antisense 59TGTGGAGAAGGAGTTCATAGC-39
257
IL-8 Sense 59-GTTGTAGTATGCCCCTAAGAG-39
Antisense 59-CTCAGGGCAAAC CTGAGTCATC-39
407
COX-2 Sense 59-CAAGGCGATCAGTCCAGAAC-39
Antisense 59-GGTAGGCTTTGCTGTCTGAG-39
464
doi:10.1371/journal.pone.0031378.t001
Figure 1. Cigarette smoke increased the nuclear levels of phosphorylated MSK1, phosphorylated and acetylated RelA/p65 in a
time-dependent manner in human bronchial and small airway epithelial cells, and in mouse lung. (A) H292, BEAS-2B and SAEC cells
were treated with or without 1% CSE (time course: 0, 15, 30, and 60 minutes). Cells were harvested, nuclear extracts were prepared and
immunoblotted for p-MSK1 (Thr581), total MSK1, phosphorylated RelA/p65 (Ser276), acetylated RelA/p65 (Lys310), and total RelA/p65. Lamin B was
used as nuclear protein loading controls. Gel pictures shown are representative of at least three separate experiments. (B) The band intensity was
measured by densitometry and data shown as fold change relative to Lamin B control. Data are shown as mean 6 SEM; *, P,0.05; **, P,0.01
significant compared with control or without treatment.
doi:10.1371/journal.pone.0031378.g001
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then permeabilized for 10 min in 0.4% Triton X-100 in PBS, and
blocked for 1 h using 10% normal goat serum with 0.4% Triton
X-100. The samples were incubated with specific primary
antibody in a humidified chamber overnight. The primary
antibody was detected with Alexa Fluor 594 goat anti-rabbit or
Alexa Flour 555 donkey anti-mouse secondary antibody (Invitro-
gen, Carlsbad, CA, USA). Nuclei were stained with 1 mg/ml
Hoechst 33342 for 1 min. Samples without primary antibodies
were used as negative controls. The coverslips were mounted onto
the slides using VectaShield (Vector Laboratories, Burlingame,
CA, USA) and viewed under a Nikon TE2000-E microscope
(Nikon, Tokyo, Japan).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed using the Imprint ChIP kit (Sigma)
according to the manufacturer’s instructions. Briefly, H292
(1.6610
6) cells were cross-linked with 1% formaldehyde for
10 min and then quenched by adding 1.25 M glycine. Cells were
centrifuged at ,180 g for 5 min and washed 3 times with 10 ml
ice-cold PBS by centrifugation. Cell nuclei were isolated and the
pellet resuspended in shearing buffer, and then sonicated 7 times
with 7 sec pulses on ice. Equal amounts of sonicated chromatin
were immunoprecipitated with 1 mg of specific antibodies [MSK1,
phospho-RelA/p65 (S276), acetylated histone H3 (Lys9) and
histone H4 (Lys12), mouse IgG as negative control and RNA
polymerase II as positive control]. Reversal of crosslinks and DNA
purification were performed on immunoprecipitated samples and
on input DNA as described in the kit. PCR amplification was
performed using a PTC-200 DNA engine (M.J. Research,
Waltham, MA) employing the following conditions: 94uC for
3 min; 32–35 cycles at 94uC for 45 sec, 60uC for 1 min, and 72uC
for 1 min; and final extension at 72uC for 10 min. Human pro-
inflammatory gene promoter sequence specific primer sequences
and amplification product sizes (bp) are listed in Table 1. The
PCR products were analyzed on a 1.5% agarose gel.
Figure 2. Cigarette smoke increased p-MSK1 (Thr581) and p-RelA/p65 (Ser276) in human bronchial and small airway epithelial cells
as demonstrated by immunocytochemistry, and in mouse lung by immunoblotting. (A) Activation of MSK1 and RelA/p65 (Ser276) in H292
cells treated with CSE (1%) for 1 h. For immunocytochemistry, cells were fixed, permeabilized, and stained for the expression of p-MSK1 (Thr581),
total MSK1, and phosphorylated RelA/p65 (Ser276) by immunofluorescence. Phosphorylated MSK1, total MSK1, and phosphorylated RelA/p65 is
shown in red, and DNA (Hoechst nuclear staining) in blue, and merge represented as dark purple or pink. Results are representative cells from three
separate experiments. The panel without primary antibodies was considered as negative control (NC). (B) Activation of MSK1 and RelA/p65 (Ser276) in
SAEC cells treated with CSE (1%) for 1 h. For immunocytochemistry, cells were fixed, permeabilized, and stained for the expression of p-MSK1
(Thr581), total MSK1, and phosphorylated RelA/p65 (Ser276) by immunofluorescence. Phosphorylated MSK1, and phosphorylated RelA/p65 is shown
in red, total MSK1 in green, and DNA (Hoechst nuclear staining) in blue, and merge represented as dark purple or pink. Results are representative cells
from three separate experiments. The panel without primary antibodies was considered as negative control (NC). (C) Nuclear levels of MSK1
(phosphorylated and total MSK1) were increased in lung tissue of mouse exposed to CS determined by immunoblot analysis. Adult C57BL/6J mice
were exposed to CS for 3 days and were sacrificed 24 hrs post-final CS exposure. Lamin B was used as protein loading control. The band intensity was
measured by densitometry and data shown as fold change relative to Lamin B control. Data are shown as mean 6 SEM (n=4/group); **, P,0.01,
significant compared to air-exposed controls. p-MSK1 (Thr581), phosphorylated MSK1.
doi:10.1371/journal.pone.0031378.g002
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Results are shown as mean 6 SEM. Statistical analysis of
significance was calculated using one-way analysis of variance
(ANOVA) followed by Tukey’s post hoc test for multigroup
comparisons using the StatView software. Image J software
(Version 1.41, National Institutes of Health, Bethesda, MD) was
used for quantification of corrected total cell fluorescence (CTCF)
by measuring cell fluorescence and densitometry analysis. P,0.05
was considered as significant, whereas P.0.05 was considered as
non-significant.
Results
CS causes activation of MSK1 and its substrate NF-kB
RelA/p65
MSK1 is activated by both mitogens and stress in different
physiological and pathological conditions [26]. We hypothesized
that CS activates MSK1, leading to phospho-acetylation of the
RelA/p65 subunit of NF-kB in human bronchial epithelial cells
(H292 and BEAS-2B), and human primary small airway epithelial
cells (SAEC). Human epithelial cells were treated with different
doses of CSE (0.1% to 1.0%) at different time points (0 min–
60 min). Cells were harvested, nuclear extracts prepared, and
immunoblot analysis performed to examine CS-induced activation
of nuclear MSK1 (MSK1 phosphorylation at Thr581) and
phospho-acetylation of RelA/p65 at Ser276 and Lys310. Inter-
estingly, nuclear accumulation of phosphorylated MSK1 (Thr581),
and p-RelA/p65 (Ser276), and levels of Ac-RelA/p65 (Lys310)
were increased in a time-dependent manner in H292, BEAS-2B
and SAEC cells, (Fig. 1A–B), as well as in mouse lung (Fig. 2C). To
further investigate CS-mediated activation of MSK1, immunocy-
tochemistry was performed in H292 and SAEC cells after 1 h CSE
(1%) treatment, using antibodies specific for p-MSK1 (Thr581),
total MSK1 and p-RelA/p65 (Ser276), and immunohistochemis-
try for MSK1 in CS-exposed mouse lung sections. CSE treatment
resulted in increased nuclear levels of p-MSK1, MSK1 and p-
RelA/p65 (Ser276) compared to non-treated controls (Fig. 2A–B).
Immunohistochemistry of mouse lung sections also revealed a
significant increase in the levels of MSK1 in alveolar epithelium,
alveolar type II cells, and airway epithelium of CS-exposed mouse
lung compared to air-exposed controls (data not shown). These
findings confirm that CS activates MSK1 and its substrate causing
phospho-acetylation of NF-kB RelA/p65 in human transformed
epithelial cells, primary small airway epithelial cells, and mouse
lung.
Figure 3. CSE increased phospho-acetylation of histone H3 (Ser10/Lys9) and acetylation of H4 (Lys12) in H292 cells. Acid extracted
histone proteins were used for immmunoblotting against anti-phospho-acetylated histone H3 (Ser10/Lys9) and acetylated histone H4 (Lys12). (A) The
levels of phospho-acetylated (histone H3 on Ser10/Lys9) and acetylated (histone H4 on Lys12) histones were increased in response to CSE in H292
cells. The band intensity was measured by densitometry and data shown as fold change relative to total histones H3/H4. Data are shown as mean 6
SEM (n=3). ***, P,0.001 significant compared to control group. p-Ac-H3, phospho-acetylated histone H3; Ac-H4, acetylated histone H4. (B)
Immunocytochemistry showing histone modifications in H292 and SAEC cells treated with CSE (1%) for 1 h. For immunocytochemistry, cells were
fixed, permeabilized, and stained for expression of phospho-acetylated histone H3 (Ser10/Lys9) and acetylated histone H4 (Lys12) by
immunofluorescence. Phospho-acetylated histone H3 and acetylated histone H4 are shown in red, and DNA (Hoechst nuclear staining) in blue,
and merge represented as dark purple or pink. Gel pictures and immunocytochemistry figures are representative of at least three separate
experiments.
doi:10.1371/journal.pone.0031378.g003
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phospho-acetylation of histone H3 and acetylation of
histone H4
Phosphorylation of histone H3 at Ser10 and acetylation of
histone H4 on Lys12 have been shown to occur early during
chromatin remodeling [10,27]. To elucidate the downstream
signaling events involved in chromatin modifications in response to
CSE treatment in H292 cells, we performed immunoblot analysis
to determine the levels of Ser10 phosphorylation and Lys9
acetylation of histone H3 and Lys12 acetylation of histone H4 in
acid-extracted histones. Phospho-acetylation of histone H3 and
acetylation of histone H4 were increased in response to CSE
treatment in H292 cells (Fig. 3A). Additionally, immunocyto-
chemistry for p-Ac-H3 (Ser10/Lys9), and Ac-H4 (Lys12) was
performed using specific antibodies in H292 and SAEC cells
treated for 1 h with CSE (1%). CSE caused phospho-acetylation of
histone H3 and acetylation of histone H4 in H292 and SAEC cells
(Fig. 3B), suggesting that CS/acrolein-mediated activation of
MSK1 further caused histone modifications.
Knock-down of MSK1 inhibits CSE-induced RelA/p65
activation and histone modifications
In order to gain mechanistic insight into MSK1-mediated
activation of RelA/p65 and posttranslational histone modifica-
tions, we determined the downstream events i.e. the phosphory-
lation of RelA/p65 (Ser276) and histone modifications in response
to CSE using a MSK1 N- and C-terminal kinase-dead mutant and
siRNA-mediated knock-down approaches, as well as using a stable
MSK1 knock-down mouse embryonic fibroblasts (MEFs).
First, we transiently transfected H292 cells with control vector
(pCMV-FLAG), an expression vector for MSK1wild-type (pCMV-
FLAG-MSK1 WT), MSK1 N-terminal kinase-dead (ND) mutant
(pCMV-FLAG-MSK1 D195A), and MSK1 C-terminal kinase-
dead (CD) mutant (pCMV-FLAG-MSK1 D565A). CSE-mediated
activation of MSK1 (p-MSK1) and phosphorylation of RelA/p65
were significantly increased in H292 cells transfected with control
vector and MSK1 wild-type. CS-induced phosphorylation of
MSK1 and RelA/p65 were modest but significantly decreased
without any change in acetylation of RelA/p65 in both MSK1 N-
Figure 4. MSK1 N- and C-terminal kinase-dead mutants in H292 cells attenuated the phosphorylation of RelA/p65 by CSE
treatment. Cigarette smoke increased the cellular levels of phosphorylated MSK1 as well as phosphorylated RelA/p65 levels in control vector (pCMV-
FLAG) and MSK1 WT (pCMV-FLAG-MSK1 wild-type) transfected human bronchial epithelial cells compared to MSK1 N- and C-terminal kinase-dead
mutants (pCMV-FLAG-MSK1 ND and pCMV-FLAG-MSK1 CD). H292 cells were transiently transfected with control vector, MSK1 WT, MSK1 N-terminal
kinase-dead (ND) mutant, MSK1 C-terminal kinase-dead (CD) mutant and treated with or without CSE (1%) after 24-48 hrs of transfection for 1 h. Cells
were harvested (1 h later). Whole cell extracts were prepared and immunoblotted for p-MSK1 (Thr581), total MSK1, phosphorylated RelA/p65
(Ser276), acetylated RelA/p65 (Lys310), and total RelA/p65. b-actin was used as protein loading control. Gel pictures are representative of at least
three separate experiments. The band intensity was measured by densitometry and data shown as fold change relative to b-actin control. Data are
shown as mean 6 SEM; **, P,0.01; ***, P,0.001, significant compared with respective control group; #, P,0.05; ##, P,0.01; significant compared
to CSE treated control vector transfected group.
doi:10.1371/journal.pone.0031378.g004
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Our results suggest that both N-terminal and C-terminal kinase
domains are crucial for MSK1 activation in human bronchial
epithelial cells.
Our second approach to examine the effect of decreased MSK1
activity involved transient siRNA-mediated knockdown of MSK1
expression. H292 cells were transiently transfected with MSK1
target-specific siRNA or with non-targeted control siRNA. MSK1
siRNA transfection resulted in a reduction in endogenous MSK1
levels of more than 70%. This reduction was associated with a
modest but significant reduction in the levels of p-MSK1 (Thr581),
total MSK1, and phosphorylated RelA/p65 (Ser276) compared to
non-targeted control siRNA transfected cells (Fig. 5). Similarly,
immunocytochemistryconfirmedthisphenomenonwhen H292cells
were transiently transfected with MSK1 siRNA and treated with
CSE by showing a significant reduction in the levels of p-MSK1 and
phosphorylated RelA/p65 (Ser276) compared to non-targeted
siRNA transfected human bronchial epithelial cells (Fig. 6A–B).
We next determined the effect of MSK1 siRNA-mediated
knockdown on activation of p-MSK1 (Thr581), and chromatin
modifications [phospho-acetylation of histone H3 (Ser10/Lys9)] in
H292 cells. Immunocytochemistry was performed in transfected
cells treated with CSE (1%) for 72 hr to measure p-MSK1, total
MSK1, and phospho-acetylation of histone H3 (Ser10/Lys9) using
specific antibodies. Knock-down of MSK1 using MSK1 siRNA
led to a significant decrease in phosphorylated and total levels of
MSK1, as well as a decrease in phospho-acetylation of histone H3
(Ser10/Lys9) in response to CSE treatment compared to non-
targeted control siRNA-transfected H292 cells (Fig. 7A–B). In
addition, the reduction in phospho-acetylation of histone H3
(Ser10/Lys9) and acetylation of histone H4 (Lys12) was also
evident in MSK1 stable knock-down mouse embryonic fibroblast
(MEF) cells treated with CSE compared to wild-type MEFs
(10T1/2 cells) as shown by immunocytochemistry (Fig. 8). These
data suggest that activation of MSK1 is a key event in response to
CS leading to NF-kB activation and histone modifications.
Figure 5. siRNA-mediated knock-down of MSK1 in H292 cells attenuated the phosphorylation of RelA/p65 by CSE treatment. MSK1
knock-down by siRNA approach attenuated the phosphorylation of RelA/p65 by CSE in human bronchial epithelial cells. H292 cells were transfected
with 100 nM scrambled siRNA (non-targeted siRNA) or siRNA directed against MSK1 (MSK1 siRNA) for 24 h, followed by starvation in serum free
medium and treated for 1 h after 72 h of transfection with CSE (1%). Whole cell lysate was prepared after 1 h treatment and assayed for effect of
MSK1 knock-down by immunoblotting. The levels of p-MSK1 (Thr581), total MSK1, phosphorylated RelA/p65 (Ser276), acetylated RelA/p65 (Lys310),
and total RelA/p65 were determined by immunoblotting. b-actin was used as a loading control. Gel pictures are representative of at least three
separate experiments. The band intensity was measured by densitometry and data shown as fold change relative to b-actin control. Data are shown
as mean 6 SEM; *, P,0.05; **, P,0.01; ***, P,0.001, significant compared with control or without treatment non-targeted siRNA group; #, P,0.05;
##, P,0.01, significant compared to CSE treated non-targeted siRNA group.
doi:10.1371/journal.pone.0031378.g005
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p65 and coactivator p300
Knock-down of MSK1 significantly reduced the MSK1-
mediated downstream signaling events activated by CS. We,
therefore, speculated that MSK1 directly interacts with and
activates RelA/p65 early during chromatin modifications, and
thus also with cofactors of RelA/p65. We performed immuno-
precipitations in H292 cells treated with or without CSE (1% for
1 hr), which were transiently transfected with MSK1 wild-type
(pCMV-FLAG-MSK1-WT) or with MSK1 N-terminal kinase-
dead mutant (pCMV-FLAG-MSK1-ND). Whole cell lysates were
prepared to isolate MSK1 complexes by anti-flag immunoprecip-
itation, and analyzed by immunoblotting for co-immunoprecipi-
tation of MSK1 with RelA/p65. CSE-mediated interaction of
MSK1 and RelA/p65 was evident in pCMV-FLAG-MSK1 wild-
type transfected cells, but the ratio of RelA/p65 and MSK1 was
not significantly changed (Fig. 9A). This may be due to the relative
increased levels of MSK1 and RelA/p65 pool in the cells treated
with CSE compared to that in control cells. Interaction between
MSK1 and RelA/p65 in CSE-treated pCMV-FLAG-MSK1-ND
transfected cells was lower compared to pCMV-FLAG-MSK1
WT transfected cells (Fig. 9A). Based on this finding and the
Figure 6. MSK1 knock-down by MSK1 siRNA in H292 cells attenuated the phosphorylation of RelA/p65 by CSE treatment
demonstrated by immunocytochemistry. CSE-induced activation of MSK1 and RelA/p65 (Ser276) in non-targeted siRNA transfected human
bronchial epithelial cells. MSK1 knock-down by siRNA approach attenuated the activation of MSK1 and phosphorylation of RelA/p65 by CSE in human
bronchial epithelial cells. H292 cells were transfected with 100 nM scrambled siRNA (non-targeted siRNA) or MSK1 siRNA for 24 h, followed by
starvation in serum free medium and then treated for 1 h (72 h post-transfection) with CSE (1.0%). For immunocytochemistry, cells were fixed,
permeabilized, and stained for the expression of p-MSK1 (Thr581), total MSK1, and phosphorylated RelA/p65 (Ser276) by immunofluorescence.
Phosphorylated MSK1, total MSK1, and phosphorylated RelA/p65 are shown in red, and DNA (Hoechst nuclear staining) in blue, and merge
represented as dark purple or pink. Results are representative cells from at least three separate experiments. The quantification of fluorescence
intensity in immunofluorescence data was measured using ImageJ and the corrected total cell fluorescence (CTCF) values were converted into fold
change values and represented as histograms. Data are shown as mean 6 SEM; **, P,0.01; ***, P,0.001, significant compared with respective
control without treatment; #, P,0.05; ##, P,0.01, significant compared to CSE treated non-targeted siRNA group.
doi:10.1371/journal.pone.0031378.g006
MSK1 Regulates Chromatin Modifications
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31378observation on involvement of both N-terminal and C-terminal
kinase domains in MSK1 activation (Fig. 4), we expect similar
effects on MSK1 interaction with RelA/p65 after transfection of
pCMV-FLAG-MSK1 CD in H292 cells and treatment with CSE.
To examine the association of native MSK1 with RelA/p65, and
with cofactor p300, we treated H292 cells with CSE (2%) for 1 h
and performed immunoprecipitation from nuclear extracts using
anti-MSK1 and anti-RelA/p65 antibodies. Interaction of MSK1
with RelA/p65 and with the cofactor p300 was evident in response
to CSE treatment as compared to control in H292 cells (Fig. 9B–
C). These findings suggest that the interactions between MSK1,
RelA/p65, and p300 occur by CSE.
To demonstrate the interplay between RelA/p65-MSK1,
MSK1-p300, and RelA/p65-MSK1-p300 in vivo, lung homoge-
nates from air- and CS-exposed mouse lungs were used for
immunoprecipitation using anti-RelA/p65 and anti-MSK1 anti-
bodies. RelA/p65 complexes isolated by anti-RelA/p65 immuno-
precipitations were analyzed by immunoblotting so as to
determine the interaction of MSK1 with RelA/p65, MSK1 with
p300, and RelA/p65 with p300. Interaction between RelA/p65-
MSK1, MSK1-p300, and RelA/p65-p300 was significantly
increased in CS-exposed mouse lung compared to air-exposed
control (Fig. 9D–E). This confirms the interplay between RelA/
p65-MSK1, MSK1-p300, as well as RelA/p65-MSK1-p300, and
activation and interaction of these complexes both in vitro in H292
cells and in vivo in mouse lungs is mediated by CS. These
interactions may play a key role in chromatin remodeling on the
promoters of pro-inflammatory genes.
CSE treatment causes the recruitment of MSK1 along
with phorphorylated RelA/p65 and acetylated histone H3
and histone H4 on the promoters of NF-kB-dependent
pro-inflammatory genes
We further demonstrated the role of MSK1 on NF-kB-driven
pro-inflammatory genes using the chromatin immunoprecipita-
tion (ChIP) assay in vitro (H292 cells). CS-induced nuclear
activation of MSK1 resulted in its localization to NF-kB-
dependent pro-inflammatory gene promoters, including IL-6,
IL-8, and COX-2. The ChIP assay revealed that upon CSE
Figure 7. MSK1 knock-down by MSK1 siRNA in H292 cells attenuated the phospho-acetylation of histone H3/H4 by CSE treatment
demonstrated by immunocytochemistry. (A) MSK1 knock-down by siRNA approach attenuated activation of MSK1 by CSE in H292 cells. CS-
induced activation of MSK1 (p-MSK1 Thr581) was observed in control siRNA transfected cells compared to MSK1 siRNA transfected human bronchial
epithelial cells. H292 cells were transfected with 100 nM scrambled siRNA (non-targeted siRNA) or siRNA directed against MSK1 (MSK1 siRNA) for
24 h, followed by starvation in serum free medium and treated for 1 h after 72 h of transfection with CSE (1.0%). For immunocytochemistry, cells
were fixed, permeabilized, and stained for the expression of p-MSK1 (Thr581), and total MSK1 by immunofluorescence. Phospho-MSK1 is shown in
red, and total MSK1 is shown green, and DNA (Hoechst nuclear staining) in blue, and merge represented as orange yellow. (B) MSK1 knock-down by
siRNA approach attenuated CSE-induced histone modifications (phospho-acetylated histone H3) in human bronchial epithelial cells. H292 cells were
transfected with 100 nM scrambled siRNA (non-targeted siRNA) or siRNA directed against MSK1 (MSK1 siRNA) for 24 h, followed by starvation in
serum free medium and treated for 1 h after 72 h of transfection with CSE (1.0%). For immunocytochemistry, cells were fixed, permeabilized, and
stained for the expression of p-Ac-H3 (Ser10/Lys9), and total MSK1 by immunofluorescence. Phospho-acetylated histone H3 is shown in red, and total
MSK1 is shown green, and DNA (Hoechst nuclear staining) in blue, and merge represented as orange yellow. Results are representative cells from at
least three separate experiments. p-Ac-H3, phospho-acetylated histone H3. Quantification of fluorescence intensity in immunofluorescence data was
measured using ImageJ and the corrected total cell fluorescence (CTCF) values were converted into fold change values and represented as
histograms. Data are shown as mean 6 SEM; *, P,0.05; ***, P,0.001, significant compared with respective control or without treatment; ###,
P,0.001, significant compared to CSE treated non-targeted siRNA group.
doi:10.1371/journal.pone.0031378.g007
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H3 (Lys9), and histone H4 (Lys12) were localized to these pro-
inflammatory gene promoters to induce gene transcription
(Fig. 10). These data suggest that CS-induced MSK1 recruitment
on the promoters of pro-inflammatory genes drives their
transcription via RelA/p65 phosphorylation and histone acety-
lation. Overall, these data establish the fact that MSK1 not only
phosphorylates transcription factor NF-kBR e l A / p 6 5a n dc a u s e s
chromatin modifications (phospho-acetylated histone H3 and
acetylated histone H4), but also results in recruitment of MSK1
and its substrates on NF-kB-responsive pro-inflammatory gene
promoters culminating in chromatin modifications and gene
transcription in response to CS.
Discussion
Cigarette smoke is the common etiological factor in the
pathogenesis of COPD. We and others have demonstrated the
role of the NF-kB signaling pathway in pro-inflammatory gene
transcription and chromatin modifications [1,2,10,28,29,30].
Studies in the past have shown that NF-kB is recruited to the
promoter of pro-inflammatory genes in CS-exposed rodent lungs,
resulting in increased histone acetylation [10,31,32,33].
MSK1 has been shown to regulate transcription of several pro-
inflammatory genes at multiple levels [34]. Transcription factor
CREB was the first MSK1 substrate to be identified [17,35].
MSK1 also phosphorylates RelA/p65 at Ser276 residue in
response to TNFa [9]. In addition to transcription factor
regulation, MSK1 can contribute to gene activation by phosphor-
ylation of chromatin proteins histone H3 (Ser10 and Ser28) and
HMG-N1 (Ser6) [11]. However, the underlying molecular
signaling mechanism that causes activation of MSK1 and
downstream signaling event, including chromatin histone modifi-
cations, in response to CS is not known. We tested the hypothesis
that CS induces histone modifications via activation of MSK1 and
phospho-acetylation of RelA/p65 followed by recruitment of
MSK1 and its substrates to the promoters of pro-inflammatory
genes, thereby increasing the transcriptional activity of pro-
inflammatory mediators in human bronchial and small airway
epithelial cells and in mouse lungs.
CS exposure resulted in phosphorylation of MSK1 at Thr581 in
transformed human bronchial epithelial cells (H292 and BEAS-
Figure 8. MSK1 knock-down using MSK1 stable knock-down MEFs attenuated the phospho-acetylation of histone H3/H4 by CSE
treatment demonstrated by immunocytochemistry. CSE induced histone modification (phosphorylated/acetylated histone H3/H4) in 10T1/2
wild-type mouse embryonic fibroblasts (MEFs) compared to stable MSK1 knock-down MEFs. Wild-type MEFs and MSK1 knock-down MEFs were
treated for 1 h with CSE (1.0%). For immunocytochemistry, cells were fixed, permeabilized and stained for the expression of p-Ac H3 (Ser10/Lys9), and
Ac-H4 (Lys12) by immunofluorescence. Phosphorylated/acetylated histone H3 and acetylated histone H4 are shown in red, and DNA (Hoechst nuclear
staining) in blue, and merge represented as purple or pink. Results are representative cells from at least three separate experiments. The panel
without primary antibodies was considered as negative control (NC). The quantification of fluorescence intensity in immunofluorescence data was
measured using ImageJ and the corrected total cell fluorescence (CTCF) values were converted into fold change values and represented as
histograms. Data are shown as mean 6 SEM; ***, P,0.001, significant compared with control or without treatment; ###, P,0.001, significant
compared to CSE treated wild-type group.
doi:10.1371/journal.pone.0031378.g008
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mouse lung. We observed similar dose-dependent activation of
MSK1 and RelA/p65 by CSE (0.1% to 1.0%) in H292, BEAS-2B
and SAEC cells (data not shown). Phosphorylation of MSK1 at
Thr581 residue is an event of activated MSK1 protein [13,36].
MSKs are activated by several mitogenic and stress stimuli, such as
epidermal growth factor (EGF), phorbol 12-myristate 13-acetate/
TPA and UV possibly via oxidative stress [17,37,38]. Our results
show that CS activates MSK1, leading to phospho-acetylation of
RelA/p65 at Ser276 and Lys310, respectively, in epithelial cells.
Similar observations were found when the cells were treated with a
component of CS, the aldehyde acrolein (data not shown). Other
studies have shown the control of phosphorylation of RelA/p65 at
multiple serine residues regulates transcriptional activity of NF-kB
RelA/p65 by TNF-a, IL-1b, UV, farnesol, respiratory syncytial
virus (RSV) in various cell types [39,40,41,42,43]. Hence, it is
possible that MSK1 activation regulates RelA/p65 phosphoryla-
tion in lung epithelial cells in response to CS. This is shown by the
evidence that CS causes a significant increase in the levels of
phosphorylated MSK1 and phospho-acetylation of RelA/p65 in
control vector and wild-type MSK1 transfected H292 cells. There
was a modest but significant reduction of MSK1 activation and
RelA/p65 phosphorylation without any change in acetylation of
RelA/p65 in MSK1 N- and C-terminal kinase-dead mutant
transfected H292 cells suggest the role of both N- and C- terminal
domains of MSK1 are crucial for it activation. Based on previous
report [17], we speculated that the kinase activity will be affected
in cells transfected with MSK1 N- and C-terminal kinase-dead
mutants without any appreciable effects on MSK1 levels.
Nevertheless, CS-induced activation of MSK1 and RelA/p65
was modest, but a significant reduction was seen in MSK1 siRNA
transfected H292 cells compared to non-targeted control siRNA
transfected cells. This suggests that the activation of RelA/p65
(Ser276) is MSK1-dependent in epithelial cells.
MSK1 contains two catalytic active kinase domains (N- and C-
terminal), which are required for proper function [13,17]. Earlier
reports show that neither of the kinase-dead mutants (N- or C-
terminal) of MSK1 possessed detectable activity nor showed any
change in the total levels of MSK1 either before or after
stimulation of cells with TPA or exposure to UV [17,42,44,45].
Therefore, both the N- and C-terminal kinase domains play an
essential role in activity of MSKs [11,42,44]. MSK1 also acts as a
regulator of inflammation [46,47]. However, the signaling
mechanism by which CS activates MSK1 is not known. It has
been shown that IKKa translocated into the nucleus and is
required for optimal NF-kB-mediated transcription and phos-
phorylation of histone H3 at Ser10 of NF-kB target genes
[10,28,48,49,50], as well as EGF-induced transcriptional regula-
tion of immediate early genes (IEGs) [51,52]. Hence, we proposed
that CS activates MSK1 via IKKa, leading to chromatin
Figure 9. MSK1 interacted with RelA/p65 and p300. (A) H292 cells were transiently transfected with wild-type MSK1 or MSK1 N-terminal kinase-
dead mutant MSK1 flag construct and treated with or without CSE (1.0%) for 1 h. Flag-tagged precipitated complexes were analyzed through
immunoblotting using anti-flag and anti-RelA/p65 antibodies. Whole cell lysate from pCMV-Flag-MSK1 wild-type transfected cells were used as lysate
control. (B) H292 cells were treated for 1 h with or without CSE (2.0%) and TNFa (10 ng/ml) was used as positive control. Nuclear extract (1000 mg)
was used for immunoprecipitation of MSK1 bound complexes and analyzed through immunoblotting using anti-MSK1, anti-RelA/p65 and anti-p300
antibodies. (C) H292 cells were treated for 1 h with or without CSE (2.0%), and TNFa (10 ng/ml) was used as positive control. Nuclear extract
(1000 mg) was used for immunoprecipitation of RelA/p65 bound complexes and analyzed through immunoblotting using anti-RelA/p65 and anti-
MSK1 antibodies. (D) CS-mediated interaction of MSK1-p300 in acute CS exposed mouse lung. Adult C57BL/6J mice were exposed to CS at 300 mg/
m
3 total particulate matter (TPM) for 3 days and were sacrificed 24 h after the final exposure. Whole tissue extract (500 mg) was used for
immunoprecipitation of MSK1 bound complexes, and analyzed by immunoblotting using anti-MSK1 and anti-p300 antibodies. (E) CS-mediated
interaction of RelA/p65 with MSK1 and p300 in acute CS exposed mouse lung. Adult C57BL/6J mice were exposed to CS at 300 mg/m
3 total
particulate matter (TPM) for 3 days and were sacrificed 24 h after the final exposure. Whole tissue extract (500 mg) was used for immunoprecipitation
of RelA/p65 bound complexes, and analyzed by immunoblotting using anti-RelA/p65, anti-MSK1 and anti-p300 antibodies. Results are representative
of at least three separate experiments.
doi:10.1371/journal.pone.0031378.g009
MSK1 Regulates Chromatin Modifications
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e31378modifications in human lung epithelial cells. In support of this, we
found that CS increases the levels of phosphorylated MSK1 and
phospho-acetylated RelA/p65 in H292 cells overexpressing IKKa
compared both to cells expressing a dominant-negative IKKa and
to non-transfected control cells. These data suggest that IKKa
plays an important role in CSE-induced activation of MSK1 and
histone modifications in epithelial cells. Immunocytochemistry
data also suggest that CS-mediated activation of MSK1 occurs via
IKKa (unpublished observations). Recently, we have reported that
NF-kB inducing kinase (NIK) activation by CS and TNFa induces
RelA/p65 and histone H3K9 acetylation in human bronchial
epithelial cells. Nuclear accumulation and recruitment of NIK on
the proinflammatory gene promoters result in NF-kB-dependent
gene activation [53].
Our data show that CS-mediated activation of MSK1 further
leads to phospho-acetylation of histone H3 (Ser10/Lys9) and
acetylation of histone H4 (Lys12) in bronchial epithelial cells.
These modifications were confirmed by LC-MS/MS analysis of
histone H3 and H4 fractions from CS-treated H292 cells. Apart
from this, MS analysis also revealed CSE-mediated phosphoryla-
tion of histone H3 at Ser28 and acetylation of histone H4 at Lys5,
Lys8, Lys12 and Lys16 (unpublished observations). Our in vitro
data are in agreement with other studies on MSK1-mediated
histone H3 Ser10 and Ser28 phosphorylation [11,54,55,56].
Earlier reports have shown that IKKa phosphorylates histone
H3 Ser10, and RelA/p65 phospho-acetylation (Ser276/Lys310)
occurs by direct interaction with CBP/p300 [10,30,48,49]. We
further demonstrate that CS-mediated activation of MSK1 leads
to phospho-acetylation of histone H3 (Ser10/Lys9), which was
significantly reduced when MSK1 was knocked down in human
bronchial epithelial cells, as well as in stable MSK1 knock-down
mouse embryonic fibroblast (MEF) treated with CSE. Similarly,
histone H3 is phosphorylated at Ser10 or Ser28 in response to
other mitogenic or stress stimuli associated with induction of IEGs
[16,44,57]. Notably, studies using MSK1 and MSK2 knock-out
MEFs or using the MSK1 dominant-negative mutant or MSK1
knock-down approaches have demonstrated that these kinases play
a vital role in phosphorylation of histone H3 Ser10 and Ser28 in
various cell lines [9,11,54,55,58,59,60]. Thus, our data highlight
the importance of MSK1-mediated nucleosomal response by CS-
mediated oxidative/carbonyl stress potentially leading to inflam-
matory response.
We have observed CS-induced direct interactions between
MSK1 and RelA/p65 in epithelial cells in vitro and in acute CS-
Figure 10. ChIP assay revealed that MSK1 is localized to pro-inflammatory gene promoters (IL-8, IL-6 and COX-2). H292 cells were
treated with CSE (1%) for 1 h. ChIP analysis was performed against MSK1, phospho-RelA/p65 (Ser276), phospho-histone H3 (Lys9) and acetylated
histone H4 (Lys12) antibodies. After reverse cross-linking, co-immunoprecipitated genomic DNA fragments were analyzed by semi-quantitative PCR
with IL-6, IL-8, and COX-2 promoter specific primer sets. IgG was used as negative control, and RNA Polymerase II antibody was used as positive
control. Input reflects the relative amount of sonicated DNA fragments present before immunoprecipitation and revealed by semi-quantitative PCR
with pro-inflammatory gene specific primers. The band intensity was measured by densitometry and data shown as fold change versus input. Data
are shown as mean 6 SEM (n=3). *, P,0.05; **, P,0.01, significant compared to respective control group.
doi:10.1371/journal.pone.0031378.g010
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coimmunoprecipitated with MSK1 and RelA/p65 suggesting that
acetylation of histones H3 and H4 in response to CS is mediated
by CBP/p300. This interaction plays a vital role in the regulation
of DNA binding by transcription factors, such as NF-kB to the
promoters of pro-inflammatory genes [61]. Recruitment of MSK1
along with other DNA-binding proteins and coactivators, such as
CBP/p300 may result in phosphorylation of chromatin proteins,
particularly histone H3 (Ser10 or Ser28), and thus activate gene
transcription [62]. MSK1 interaction with coactivators (CBP/
p300 and ER81) and other chromatin modifying enzymes
stimulate the transactivation of target genes [16,45,60]. Earlier
reports have described that phosphorylation of RelA/p65 at
Ser276 enhances its assembly with CBP/p300 [14,39,40], and this
interaction is augmented due to the acetylation of a key lysine
residues in RelA/p65 (Lys310), which potentiates transcriptional
activity [7,63]. Similarly, we have previously reported that CS/
aldehyde- or LPS-induced lung inflammation resulted in acetyla-
tion of RelA/p65 and histone modifications (phospho-acetylation
of histone H3) via the interaction of RelA/p65 with coactivator
CBP/p300 in mouse lung [30,53]. Thus, based on our data, we
conclude that CS/aldehyde-induced MSK1 activation leads to the
formation of a complex that includes MSK1, RelA/p65 and CBP/
p300, which localizes to pro-inflammatory gene promoters and
modifies histones to promote transcriptional activation.
We also speculated that MSK1-mediated phosphorylation of
RelA/p65 at Ser276 is required for the RelA/p65 and p300 in
response to CSE. In support of this, we found that a S276A
mutant Flag-tagged RelA/p65 protein did not coimmunoprecipi-
tate with p300 either in the presence or absence of CSE
(unpublished observations). This suggests a crucial role for
RelA/p65 phosphorylation as an important event in CS-mediated
MSK1 activation and NF-kB signaling. Our ChIP analysis
revealed that MSK1, and its substrates RelA/p65 (Ser276),
acetylated histone H3 (Lys9) and histone H4 (Lys12) are recruited
to the promoters of pro-inflammatory genes in response to CS in
epithelial cells. This is similar to the findings that CS causes
recruitment of IKKa and RelA/p65 to the promoters of pro-
inflammatory genes, such as MIP-2 and IL-6 in mouse lung
[10,31]. Earlier study by Gilmour et al. demonstrated a role of
histone H4 acetylation in regulation of IL-8 gene expression using
the ChIP assay showing an increased association of acetylated H4
on IL-8 gene promoter following TSA, PM10, and TNF
treatments after 24 h [64]. In light of this, we propose a similar
phenomenon that CSE treatment in H292 cells for 24 hrs may
show a dynamic recruitment of MSK1, phosphorylated RelA/
p65, and acetylated histone H3 and H4 on the promoters of pro-
inflammatory genes. Thus, MSK1 kinase appears not only to
modify and activate the factors involved in transcriptional
regulation, but also participate in the complex that mediates
chromatin remodeling on pro-inflammatory gene promoters. This
is corroborated by the findings of Beck et al. who demonstrated the
presence of MSK1 on inflammatory gene promoters, proximal to
or in the kB-site, which was significantly reduced by glucocorti-
coids in A549 epithelial cells [43]. Similarly, other studies have
demonstrated that MSK1 and its substrates RelA/p65 (Ser276)
and phospho-histone H3 (Ser10) were localized to pro-inflamma-
tory promoters [9,65,66]. Thus, MSK1 plays an active role in
linking the signaling cascade and gene transcription in response to
pro-inflammatory environmental stimuli, such as CS and alde-
hydes.
In summary, we have demonstrated a novel role of MSK1 in
CS-induced activation of NF-kB RelA/p65 (Ser276/Lys310) and
chromatin modifications in human lung epithelial cells and mouse
lung (Fig. 11). MSK1 serves as a specific NF-kB RelA/p65 kinase,
promoting transcriptional activation of RelA/p65-dependent pro-
Figure 11. A schematic model showing the role of MSK1 in cigarette smoke-induced NF-kB signaling and chromatin modifications.
Cigarette smoke/aldehyde/oxidative stress via activation of MSK1 results in phosphorylation, and nuclear transclocation of NF-kB RelA/p65. Activated
nuclear MSK1 subsequently causes chromatin modifications of histones (phospho-acetylation of histone H3 [Ser10/Lys9] and acetylation of histone
H4 [Lys12]). MSK1 N-terminal kinase dead mutant, siRNA-mediated knock-down and stable MSK1 knock-down MEFs represses the nuclear MSK1,
phosphorylation of RelA/p65, and phospho-acetylation of histone H3 and acetylation of histone H4. CS activates MSK1 which forms a complex with
NF-kB RelA/p65 and coactivator p300 which further mediates transcriptional activation of NF-kB-dependent pro-inflammatory genes (IL-6, IL-8 and
COX-2). (q, Induction; w inhibition).
doi:10.1371/journal.pone.0031378.g011
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RelA/p65. Knock-down of MSK1 reduces CSE-induced activa-
tion of MSK1, RelA/p65 phosphorylation and posttranslational
modifications of histones. CS-induced interactions between
MSK1, RelA/p65 and p300 play a crucial role in sustained pro-
inflammatory gene transcription by causing acetylation of RelA/
p65 at Lys310, and modulating chromatin modifications at specific
histone residues both in vitro and in vivo. CSE-induced MSK1-
mediated phosphorylation of RelA/p65 at Ser276 is required for
the interaction of RelA/p65 with p300. The ChIP assay
demonstrates that MSK1 and its substrates associate with the
promoters of NF-kB-dependent pro-inflammatory genes. These
findings provide direct evidence that MSK1 is a kinase that plays a
crucial role in CS-induced chromatin modifications. Thus, MSK1
represents a potential target for therapy in controlling CS-
mediated chronic inflammatory response seen in several diseases,
including COPD and lung cancer.
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